The evidence

The Kanna Research Library.

Everything we say about kanna traces back to a source. This is that source list: every human study the kanna claims on this site rest on, summarized without spin, each with its PubMed ID and DOI so you can read the paper yourself. It is a small, young, mostly-Zembrin evidence base, and we say so plainly.

4
core studies cited
3
human trials
~74
total participants (disclosed)
100%
PMID-verified

Read this first: what the evidence is, and isn't

The human research on kanna is genuinely promising but genuinely small. It is a handful of short studies, most on one patented, standardized extract (Zembrin), several with industry involvement, and the largest enrolled 37 people. That is enough to describe a mechanism and a safety signal honestly. It is not enough to claim kanna treats any condition, and nobody here does. We cite these papers to stay grounded, not to oversell them.

The studies

In order of publication. Last reviewed 2026-07-01.

  1. Harvey et al., 2011

    Journal of Ethnopharmacology

    Pharmacological actions of the South African medicinal and functional food plant Sceletium tortuosum and its principal alkaloids

    Harvey AL, Young LC, Viljoen AM, Gericke NP (2011)

    What it established: Identified kanna's dual mechanism, serotonin-reuptake inhibition (5-HT transporter) and PDE4 inhibition, in vitro.

  2. Terburg et al., 2013

    Neuropsychopharmacology

    Acute effects of Sceletium tortuosum (Zembrin), a dual 5-HT reuptake and PDE4 inhibitor, in the human amygdala and its connection to the hypothalamus

    Terburg D, Syal S, Rosenberger LA, et al. (2013)

    What it established: A single 25 mg dose of standardized extract reduced amygdala reactivity to fearful faces on fMRI (n=16).

  3. Nell et al., 2013

    Journal of Alternative and Complementary Medicine

    A randomized, double-blind, parallel-group, placebo-controlled trial of Extract Sceletium tortuosum (Zembrin) in healthy adults

    Nell H, Siebert M, Chellan P, Gericke N (2013)

    What it established: A 3-month placebo-controlled trial (n=37) found 8 mg and 25 mg/day were well-tolerated, with no significant changes in vitals or blood chemistry.

  4. Chiu et al., 2014

    Evidence-Based Complementary and Alternative Medicine

    Proof-of-Concept Randomized Controlled Study of Cognition Effects of the Proprietary Extract Sceletium tortuosum (Zembrin) Targeting Phosphodiesterase-4 in Cognitively Healthy Subjects

    Chiu S, Gericke N, Farina-Woodbury M, et al. (2014)

    What it established: A 3-week randomized study (n=21) reported improved cognitive set flexibility and executive function vs placebo.

Every claim traces to a source

If an article says kanna does something, it links the study behind it. No source, no claim.

We report the limits, not just the wins

Sample sizes, Zembrin-only scope, and industry involvement are stated, not buried.

Verified, never invented

Every PMID and DOI here was checked against PubMed. We would rather cite four real studies than forty fake ones.

Start with the science guides

This library summarizes published research for general education; it is not medical advice and study findings do not establish that kanna treats, cures, or prevents any condition. Kanna is a botanical supplement not evaluated by the FDA. Kanna raises serotonin, so do not combine it with SSRIs, SNRIs, MAOIs, or other serotonergic medications without medical advice, and avoid it in pregnancy.